PD-1 checkpoint inhibitor/PD-L1 checkpoint inhibitor (Shenyang Pharmaceutical University/Harbin Medical University)

N/A

Report date: 2025/03/20 15:32:21
NME

Base Information

Drug NamePD-1 checkpoint inhibitor/PD-L1 checkpoint inhibitor (Shenyang Pharmaceutical University/Harbin Medical University)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProgrammed death-ligand 1 blockersProgrammed cell death protein 1 blockers
TargetsProgrammed cell death protein 1Programmed death-ligand 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShenyang Pharmaceutical University
China Registration ClassN/A

Develop Information

Active CompaniesHarbin Medical UniversityShenyang Pharmaceutical University
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A